MAIA Biotechnology Inc. (NYSE AMERICAN: MAIA) Stock Information | RedChip

MAIA Biotechnology Inc. (NYSE AMERICAN: MAIA) Listen to this Section


$2.93
+0.0800 ( +2.81% ) 49.0K

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Market Data


Insider Ownership Transactions

Total Amount Purchased: -150,723.00 | $ -441,618.39

Date Type Amount Purchased Purchaser
2024-03-15 Buy 170940.00 Louie Ngar Yee
2024-03-15 Buy 69282.00 Luput Cristian
2024-01-26 Sale -10000.00 Himmelreich Jeffrey C
2024-01-26 Sale -200000.00 Vitoc Vlad
2024-01-26 Sale -100000.00 Gryaznov Sergei
2024-01-03 Sale -15418.00 Guerrero Ramiro
2024-01-03 Sale -19273.00 Smith Stan
2024-01-03 Sale -15418.00 Luput Cristian
2024-01-03 Sale -15418.00 CHAOUKI STEVEN M
2024-01-03 Sale -15418.00 Theagene Jean-Manasse

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 17 Apr 23, 2024
def Proxies and info statements 3 Apr 16, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
8-k 8K-related 13 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
8-k 8K-related 16 Mar 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.